Is 3689.HK overvalued or undervalued?

3689.HK currently has a P/E ratio of 5.73. Relative to the sector average of 26.80, this suggests the stock may be undervalued. A higher P/E than peers means investors are paying more for each unit of earnings, often because they expect faster future growth. However, if that growth does not materialize, the stock can appear overvalued. A lower P/E may indicate weaker growth expectations or higher risk, but it can also signal a potential valuation discount.

How can I buy Guangdong Kanghua Healthcare Group Co., Ltd. stock?

Guangdong Kanghua Healthcare Group Co., Ltd. trades on HKSE. Investors in Latin America can buy it through international and regional brokerage and investment platforms. You simply need a valid government ID or passport to get started.

Can I buy fractional shares of 3689.HK?

Yes. Through fractional investing, you can invest exactly the amount you want, starting with as little as $1 or $5 USD (depending on what investment platform you use), and own a proportional piece of the company.

Does buying 3689.HK protect my money against local inflation?

Many investors in Latin America buy international stocks like 3689.HK to protect their purchasing power. Because 3689.HK is priced in foreign currency, your investment is tied to a hard currency. If your local currency devalues against the foreign currency, usually USD or Euro, the underlying value of your stock portfolio remains protected from local inflation.

Do I need a foreign bank account or a Visa to buy 3689.HK shares?

No. A common misconception is that you need a foreign bank account or a foreign visa to invest in international stocks. Today, modern investment platforms allow you to fund your account using local bank transfers or local payment methods right from your home country.

Is 3689.HK a suitable investment for my portfolio?

There is no universal answer, since fit depends on your situation, not just the stock. Think about three things: how well 3689.HK diversifies what you already own, whether you can stomach its price swings given your risk tolerance, and how long you plan to stay invested. As a rule, a single stock works best as one piece of a broader asset allocation and with a multi-year time horizon. This is general information, not personalized financial advice.

All stocks3689.HK

Guangdong Kanghua Healthcare Group Co., Ltd.

HK$1.88+HK$0.00+0.00%

HKSE / HKD

Market cap

HK$629M

P/E

5.7

EPS (TTM)

HK$0.04

Dividend yield

10.11%

Beta

0.46

1Y return

-3.59%

Deposit US$200 and get US$50 for freeT&C apply. Your capital is at risk.Invest with

Compare, tap a companyup to 2 at once

Deposit US$200 and get US$50 for freeT&C apply. Your capital is at risk.Invest with

Financials

The numbers behind the company

Revenue vs net income

RevenueNet income

$308M2021

$267M2022

$288M2023

$282M2024

$282M2025

Financial health

Gross margin

Operating margin

ROE

ROA

Debt to equity0.31Low
Current ratio1.10
Cash ratio0.25
Net margin4.9%
Free cash flow—

Valuation

Is it expensive right now

P/E vs the market

scale 0–50

0153050

3689.HK5.7
Healthcare sector median26.8
S&P 50022.0

Trades about 79% below its sector, cheaper than its peers on earnings.

Ratios

PEG0.21
Price to book0.36
EPS (TTM)HK$0.04
Payout ratio5,225%
FCF yield45.13%

Range & risk

HK$1.35HK$2.28

Trading in the middle of its 52-week band

Beta0.46

Profile

What Guangdong Kanghua Healthcare Group Co., Ltd. actually does

Guangdong Kanghua Healthcare Group Co., Ltd. primarily operates private hospitals in the People's Republic of China. The company operates through four segments: Hospital Services, Rehabilitation and Other Healthcare Services, Haemodialysis Services, and Elderly Healthcare Services. It provides inpatient and outpatient healthcare, and physical examination services. The company also offers reproductive medicine; plastic and aesthetic surgery; and laser treatment services. In addition, it provides rehabilitation services to patients with physical or mental disabilities; treatments that replicate kidney's function to remove wastes in blood for patients with kidney conditions; and other healthcare-related services, including elderly care and training service for the disabled. Further, the company offers elderly healthcare services, including assisted living, adult daycare, long-term care, residential care, and hospice care to the aged patients. Additionally, it operates Kanghua Hospital, Renkang Hospital, and Kangxin Hospital names; and offers management, hospital management, and property holding services. Guangdong Kanghua Healthcare Group Co., Ltd. was formerly known as Guangdong Kanghua Healthcare Co., Ltd. and changed its name to Guangdong Kanghua Healthcare Group Co., Ltd. in August 2024. The company was incorporated in 2002 and is based in Dongguan, China. Guangdong Kanghua Healthcare Group Co., Ltd. operates as a subsidiary of Dongguan Kanghua Investment Group Co., Ltd.

CEO

Wang Zhi Chen

Employees

3,728

Headquarters

Dongguan, GD

Founded

2016-11-08

Company website

If you had invested a decade ago

Loading the full price history…

Run your own numbers

Past performance is not a forecast.

ETFs

Own it inside an ETF instead

Vanguard S&P 500

Vanguard Total Stock Market

Vanguard Total World Stock

Invesco QQQ

SPDR S&P 500

iShares Russell 2000

Community sentiment

Bullish—

Distribution

Bearish0%
Neutral0%
Bullish0%

Track it without buyingTrack it

no account needed

Save 3689.HK and get told when something moves.

Get updates

A clear, direct weekly summary.

Keep looking

Q&A

Questions people ask

3689.HK has a beta of 0.46, which indicates how sensitive it has historically been to movements in its broader market. A beta below 1 indicates lower relative volatility than the market. Beta is based on historical data and does not predict future performance.

Guangdong Kanghua Healthcare Group Co., Ltd.